Skip to content

KLRS KLRS Cash ratio

Cash ratio at other companies

Eli Lilly logo
Eli LillyLLY
0.1×0.0×
Merck & Co. logo
Merck & Co.MRK
0.2×-0.1×
Amgen logo
AmgenAMGN
0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.6×-0.3×
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
2.1×0.0×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
14×+4.8×

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Calculated from KLRS’s reported figures.

Based on the most recent quarter.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's cash ratio?
KLRS (KLRS) reported cash ratio of 4.3× in Q1 2026.
How has KLRS's cash ratio changed year-over-year?
KLRS's cash ratio decreased by 69.9% year-over-year, from 14.1× to 4.3×.
What is the long-term trend for KLRS's cash ratio?
Over 4 years (2021 to 2025), KLRS's cash ratio has grown at a 17.3% compound annual growth rate (CAGR), from 5.3× to 10.1×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.